Enovix (NASDAQ:ENVX) Releases Earnings Results, Beats Expectations By $0.02 EPS

Enovix (NASDAQ:ENVX) announced its quarterly earnings results on Wednesday. The company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.02, FiscalAI reports. Enovix had a negative net margin of 473.89% and a negative return on equity of 60.98%. The company had revenue of $9.02 million for the quarter, compared to analysts’ expectations of $8.43 million. During the same quarter in the previous year, the company earned ($0.13) earnings per share. Enovix’s quarterly revenue was up 20.8% on a year-over-year basis. Enovix updated its Q3 2026 guidance to -0.170–0.130 EPS.

Here are the key takeaways from Enovix’s conference call:

• Enovix’s lead smartphone customer confirmed its cells surpassed 1,000 cycles in the 0.2C discharge test, an important qualification milestone. A final accelerated hybrid cycle-life test is underway, with completion expected by year-end 2026 before field testing and potential 2027 production.
• Smart eyewear entered early commercial revenue, with approximately 2,100 batteries shipped in Q2 and about 19,000 packs expected in Q3 as part of a 50,000-unit order. Management expects volumes to grow as customer deployments expand, although the business will likely pressure margins during its initial ramp.
• The South Korea-based drone, defense, and industrial pipeline grew 41% sequentially to approximately $183 million, including more than $100 million in drone opportunities and over $40 million in active testing or design-in stages. New capacity targeting roughly 1 million units annually is expected to come online in mid-2027.
• Q2 revenue rose 21% year over year to $9 million, while the company recorded its seventh consecutive quarter of positive gross profit and ended with approximately $552 million in cash and marketable securities. Enovix still posted a non-GAAP operating loss of $28.8 million and expects a $29 million-$32 million loss in Q3 as it continues investing in qualification and manufacturing scale-up.
• Manufacturing execution improved, with Fab2 integral yield increasing for the third consecutive quarter and Zone 1 dicing yield rising to approximately 84% from 80% in Q1. Management expects a hybrid laser-mechanical dicing configuration to materially improve throughput ahead of planned 2027 production volumes.

Enovix Stock Performance

Shares of ENVX opened at $4.43 on Friday. The company has a quick ratio of 10.65, a current ratio of 10.97 and a debt-to-equity ratio of 2.14. The stock has a market cap of $966.40 million, a P/E ratio of -5.47 and a beta of 2.32. The business’s 50 day moving average price is $5.39 and its 200-day moving average price is $5.88. Enovix has a 52 week low of $3.67 and a 52 week high of $14.21.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in the stock. Parallel Advisors LLC grew its stake in shares of Enovix by 51.9% in the third quarter. Parallel Advisors LLC now owns 3,926 shares of the company’s stock worth $39,000 after acquiring an additional 1,342 shares during the last quarter. Mackenzie Financial Corp purchased a new position in shares of Enovix in the 4th quarter worth about $77,000. CIBC Asset Management Inc bought a new position in Enovix in the 4th quarter worth about $78,000. Wilmington Savings Fund Society FSB bought a new position in Enovix in the 3rd quarter worth about $80,000. Finally, Cibc World Markets Corp purchased a new stake in Enovix during the 4th quarter valued at about $82,000. Hedge funds and other institutional investors own 50.92% of the company’s stock.

Analysts Set New Price Targets

Several analysts have weighed in on the company. JPMorgan Chase & Co. cut Enovix from a “neutral” rating to an “underweight” rating in a research report on Wednesday, May 6th. Benchmark lowered their target price on Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a research note on Thursday, May 14th. Oppenheimer reduced their price target on Enovix from $24.00 to $21.00 and set an “outperform” rating on the stock in a research note on Thursday, May 14th. Weiss Ratings reissued a “sell (e+)” rating on shares of Enovix in a research report on Wednesday, July 8th. Finally, B. Riley Financial dropped their target price on shares of Enovix from $10.00 to $9.00 and set a “buy” rating on the stock in a report on Thursday. Six investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $12.32.

Trending Headlines about Enovix

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: Enovix reported second-quarter adjusted earnings of a $0.13-per-share loss, better than the $0.15 loss analysts expected. Revenue reached $9.02 million, up 20.8% year over year and above estimates of approximately $8.43 million. Enovix Q2 earnings report
• Positive Sentiment: Analyst sentiment remains bullish. Cantor Fitzgerald reaffirmed its “overweight” rating and set a $25 price target, while B. Riley maintained a “buy” rating despite reducing its target from $10 to $9. Both targets imply substantial upside from recent trading levels. Analyst ratings reported by Benzinga
• Neutral Sentiment: Management highlighted potential demand from smartphones, wearables and defense markets on the earnings call. These opportunities could support future growth, but they depend on successful production expansion and customer adoption. Enovix Q2 earnings call transcript
• Negative Sentiment: Third-quarter revenue guidance of $9 million to $10 million came in below the $10.3 million analyst consensus, raising concerns about near-term growth. EPS guidance of a $0.17-to-$0.13 loss also confirms that Enovix remains unprofitable. Enovix second-quarter results
• Negative Sentiment: The stock fell despite the earnings beat, suggesting investors are prioritizing the revenue outlook and ongoing commercialization risks over the modest EPS outperformance. Enovix continues to report deeply negative profitability metrics, including a net margin near negative 500%.

Enovix Company Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.